要抢诺和诺德饭碗?这款国产减肥药太猛了

阿尔法工场研究院
13 hours ago

导语:一旦获批,赛湾的艾可鲁肽将在中国市场与诺和诺德的Wegovy、礼来的Zepbound,以及信达生物制药公司展开竞争。中国一家生物科技公司研发的减肥药在后期临床试验中帮助患者显著减重,有望成为诺和诺德(Novo Nordisk A/S)和礼来(Eli Lilly & Co.)畅销药物的有力竞争者。杭州赛湾生物科技有限公司(Hangzhou Sciwind Biosciences Co.)表示,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10